Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 50B pseudogene (ENSG00000270248) is a non-coding genomic locus with sequence similarity to the functional Transmembrane protein 50B gene (TMEM50B), but has accumulated disabling mutations and does not encode a functional protein product[7][1][3]. Pseudogenes are regarded as defunct remnants of coding genes and are generally not translated into proteins nor considered canonical therapeutic targets[1][5]. While some pseudogenes in the human genome may exhibit low-level transcription or potential regulatory roles, there is no evidence that this TMEM50B pseudogene is functional, disease-associated, or relevant for drug discovery. Its status in major gene databases confirms it is non-coding; for any functional or drug discovery analyses, the protein-coding TMEM50B gene or protein would be appropriate, not its pseudogene[7][2][6]. If you intended to refer to the functional target, use "Transmembrane protein 50B" (TMEM50B, ENSG00000142188); otherwise, the pseudogene is not a valid drug discovery or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 50B pseudogene.